Double‐blind study of interferon administration in renal transplant recipients

W. WEIMAR*, H. SCHELLEKENS, L. D.F. LAMEIJER, N. MASUREL, V. G. EDY, A. BILLIAU, P. DE SOMER

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Abstract. In a double‐blind trial renal allograft recipients were treated with fibroblast interferon preparations for 3 months in an attempt to prevent viral infections. Interferon therapy did not reduce the overall incidence of viral infections. No adverse effects were noted on liver function, platelet counts. or leucocyte counts, or acute rejection episodes.

Original languageEnglish
Pages (from-to)255-258
Number of pages4
JournalEuropean Journal of Clinical Investigation
Volume8
Issue number4
DOIs
Publication statusPublished - 1 Jan 1978

Keywords

  • Interferon
  • renal transplantation
  • viral infections

Fingerprint

Dive into the research topics of 'Double‐blind study of interferon administration in renal transplant recipients'. Together they form a unique fingerprint.

Cite this